Design and Subject Characteristics in the Federally-Funded Citalopram Trial in Children with Pervasive Developmental Disorders

被引:6
|
作者
Scahill, Lawrence [1 ,2 ]
McCracken, James T. [3 ]
Bearss, Karen [1 ,2 ]
Robinson, Fay [4 ]
Hollander, Eric [5 ]
King, Bryan [6 ]
Bregman, Joel [7 ]
Sikich, Lin [8 ]
Dukes, Kimberly [4 ]
Sullivan, Lisa [9 ]
Anagnostou, Evdokia [5 ]
Donnelly, Craig [6 ]
Kim, Young-Shin
Ritz, Louise [10 ]
Hirtz, Deborah [11 ]
Wagner, Ann [10 ]
机构
[1] Yale Univ, Sch Nursing, New Haven, CT 06536 USA
[2] Yale Univ, Ctr Child Study, New Haven, CT 06536 USA
[3] Univ Calif Los Angeles, Los Angeles, CA USA
[4] DM STAT, Boston, MA USA
[5] Mt Sinai Sch Med, New York, NY USA
[6] Dartmouth Med Sch, Hanover, NH USA
[7] N Shore Long Isl Jewish Hlth Syst, Manhasset, NY USA
[8] Univ N Carolina, Chapel Hill, NC USA
[9] Boston Univ, Boston, MA 02215 USA
[10] NIMH, Bethesda, MD 20892 USA
[11] Natl Inst Neurol Disorders & Stroke, Bethesda, MD USA
关键词
Autism; Serotonin reuptake inhibitors; Citalopram; Double-blind method; Repetitive behavior; AUTISM SPECTRUM DISORDERS; GASTROINTESTINAL SYMPTOMS; YOUNG-PEOPLE; RISPERIDONE; PREVALENCE;
D O I
10.1007/s10803-011-1251-8
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
The Studies to Advance Autism Research and Treatment Network conducted a randomized trial with citalopram in children with Pervasive developmental disorders (PDDs). We present the rationale, design and sample characteristics of the citalopram trial. Subjects (128 boys, 21 girls) had a mean age of 9.3 (+/- 3.12) years; 132 (88.6%) were diagnosed with autistic disorder (4.7% with Asperger's Disorder; 6.7% with PDD-not otherwise specified). Less than half of the subjects were intellectually disabled; 117 (78.5%) were rated Moderate or Marked on the Clinical Global Impression for Severity. Study measures were similar to previous Research Units on Pediatric Psychopharmacology trials. Subjects in this trial were slightly older and more likely to have complaints of repetitive behavior than participants in RUPP trials.
引用
收藏
页码:432 / 440
页数:9
相关论文
共 50 条
  • [1] Design and Subject Characteristics in the Federally-Funded Citalopram Trial in Children with Pervasive Developmental Disorders
    Lawrence Scahill
    James T. McCracken
    Karen Bearss
    Fay Robinson
    Eric Hollander
    Bryan King
    Joel Bregman
    Lin Sikich
    Kimberly Dukes
    Lisa Sullivan
    Evdokia Anagnostou
    Craig Donnelly
    Young-Shin Kim
    Louise Ritz
    Deborah Hirtz
    Ann Wagner
    Journal of Autism and Developmental Disorders, 2012, 42 : 432 - 440
  • [2] A retrospective assessment of citalopram in children and adolescents with pervasive developmental disorders
    Couturier, JL
    Nicolson, R
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2002, 12 (03) : 243 - 248
  • [3] Use of citalopram in pervasive developmental disorders
    Namerow, LB
    Thomas, P
    Bostic, JQ
    Prince, J
    Monuteaux, MC
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2003, 24 (02): : 104 - 108
  • [4] A prospective open trial of guanfacine in children with pervasive developmental disorders
    Scahill, Lawrence
    Aman, Michael G.
    McDougle, Christopher J.
    McCracken, James T.
    Tierney, Elaine
    Dziura, James
    Arnold, Eugene
    Posey, David
    Young, Christopher
    Shah, Bhavik
    Ghuman, Jaswinder
    Ritz, Louise
    Vitiello, Benedetto
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (05) : 589 - 598
  • [5] Characteristics of mobile robotic toys for children with pervasive developmental disorders
    Michaud, F
    Duquette, A
    Nadeau, I
    2003 IEEE INTERNATIONAL CONFERENCE ON SYSTEMS, MAN AND CYBERNETICS, VOLS 1-5, CONFERENCE PROCEEDINGS, 2003, : 2938 - 2943
  • [6] Trial Design Challenges When Combining Medication and Parent Training in Children with Pervasive Developmental Disorders
    Scahill, Lawrence
    Aman, Michael G.
    McDougle, Christopher J.
    Arnold, L. Eugene
    McCracken, James T.
    Handen, Benjamin
    Johnson, Cynthia
    Dziura, James
    Butter, Eric
    Sukhodolsky, Denis
    Swiezy, Naomi
    Mulick, James
    Stigler, Kimberly
    Bearss, Karen
    Ritz, Louise
    Wagner, Ann
    Vitiello, Benedetto
    JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2009, 39 (05) : 720 - 729
  • [7] Trial Design Challenges When Combining Medication and Parent Training in Children with Pervasive Developmental Disorders
    Lawrence Scahill
    Michael G. Aman
    Christopher J. McDougle
    L. Eugene Arnold
    James T. McCracken
    Benjamin Handen
    Cynthia Johnson
    James Dziura
    Eric Butter
    Denis Sukhodolsky
    Naomi Swiezy
    James Mulick
    Kimberly Stigler
    Karen Bearss
    Louise Ritz
    Ann Wagner
    Benedetto Vitiello
    Journal of Autism and Developmental Disorders, 2009, 39 : 720 - 729
  • [8] Open trial of risperidone in 24 young children with pervasive developmental disorders
    Masi, G
    Cosenza, A
    Mucci, M
    Brovedani, P
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2001, 40 (10): : 1206 - 1214
  • [9] Psychotherapy of children with pervasive developmental disorders
    Ruberman, L
    AMERICAN JOURNAL OF PSYCHOTHERAPY, 2002, 56 (02) : 262 - 273
  • [10] Pervasive developmental disorders in preschool children
    Chakrabarti, S
    Fombonne, E
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (24): : 3093 - 3099